Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Immunolymphoscintigraphy with Indium-111 labeled T101 monoclonal antibody

Conference · · J. Nucl. Med.; (United States)
OSTI ID:5938610
The authors have demonstrated specific modal and cutaneous uptake of In-111 T101 (a pan T-cell monoclonal antibody) after intravenous (IV) infusion into patients with cutaneous T-cell lymphoma (CTCL); however since animal studies have shown more efficient lymph node (LN) uptake after subcutaneous (SC) injection, this technique was applied to several patients with CTCL. Serial gamma camera images were obtained after SC injection of 500 ..mu..Ci In-111 T101 (100 ..mu..g, 500 ..mu..g or 1 mg) into the webs between the toes. Within minutes, lymphatic vessels in the legs as well as femoral, inguinal and iliac LN were visualized in all patients. Computer-analysis of serial images demonstrated that LN counts reached maximum at 24 hr and remained stable through 96 hr. At 24 hrs, femoral and inguinal LN collectively contained 18% to 51% of the injected dose (ID), and the injection site retained from 23% to 51% of the ID. In contrast to the results of IV injection, the liver, spleen, marrow and supradiaphragmatic LN (cervical, hilar, and axillary) contained much less radiolabel than did subdiaphragmatic LN. Inguinal lN biopsies showed up to 2% of the ID per gram. Low (100 ..mu..g) dose administration resulted in strong uptake in inguinal and iliac LN with weak uptake in periaortic LN, whereas 500 ..mu..g and above produced strong uptake in all subdiaphragmatic LN. These findings suggest highly efficient binding in LN proximal to the injection site, followed by more distant uptake as the proximal sites approach saturation, and demonstrate that lymphatic delivery of monoclonal antibodies can be used to target cells in human LN.
Research Organization:
National Institutes of Health, Bethesda, MD
OSTI ID:
5938610
Report Number(s):
CONF-850611-
Conference Information:
Journal Name: J. Nucl. Med.; (United States) Journal Volume: 26:5
Country of Publication:
United States
Language:
English

Similar Records

Immunolymphoscintigraphy and the dose dependence of /sup 111/In-labeled T101 monoclonal antibody in patients with cutaneous T-cell lymphoma
Journal Article · Sat Nov 14 23:00:00 EST 1987 · Cancer Res.; (United States) · OSTI ID:5784340

Immunolymphoscintigraphy in patients with lymphoma after subcutaneous injection of indium-111-labeled T101 monoclonal antibody
Journal Article · Wed Dec 31 23:00:00 EST 1986 · J. Nucl. Med.; (United States) · OSTI ID:6845331

Tissue distribution and serum kinetics of T101 monoclonal antibody during passive anti-cancer therapy
Journal Article · Wed Oct 01 00:00:00 EDT 1986 · Clin. Immunol. Immunopathol.; (United States) · OSTI ID:5008151